Home > Blogs > Genome Library > Beyond Synthesis Throughput: What Makes an Oligo Pool Truly Usable?
Beyond Synthesis Throughput: What Makes an Oligo Pool Truly Usable?

For years, discussions around chip-based oligo pool synthesis have been dominated by one metric: throughput. One million or two million oligos, sequence coverage, and synthesis capacity have become the primary benchmarks in technical comparisons.

But these numbers only tell part of the story.

A fundamental distinction exists between a pool that can be synthesized and one that is genuinely suitable for downstream experiments. The difference is not simply whether the sequences can be manufactured, but whether their abundance and sequence fidelity can be sufficiently controlled.

This gap is not defined by the physical limits of the synthesis instrument alone. It lies in the usability of the resulting library. The proportion of usable molecules in a pool is shaped by multiple factors, including abundance uniformity and sequence error profiles—not throughput alone.

Throughput answers the question,how many sequences can be produced? Usability answers a more important one: How reliably can those sequences support downstream experiments?

Yet the latter remains one of the least quantified considerations during vendor selection.


1. What Does Oligo Pool Uniformity Really Mean?

In Synbio Technologies' Syno® chip-based synthesis platform, one key quality metric is that more than 90% of oligos fall within a 2.5-fold abundance range.

This specification is more than a routine QC number. It reflects the platform's ability to control sequence representation across a large oligo pool.

In inkjet-based chip synthesis, individual oligos are synthesized in isolated microdroplets at designated reaction sites, helping prevent cross-contamination between synthesis reactions. However, synthesis efficiency can be highly sensitive to local reaction conditions.

Small variations in droplet evaporation rates, temperature gradients across different regions of the printhead, or batch-to-batch consistency in chip surface modifications can all influence the final abundance of individual oligos.

The 2.5-fold range represents an engineering control boundary achieved by minimizing these unavoidable physical variations through process optimization.


Why does this matter downstream?

The impact of abundance variation depends largely on the experimental design.

For genome-wide CRISPR screening, a 2.5-fold difference in sgRNA abundance may be manageable when sufficient library coverage and sequencing depth are maintained. Screening performance is generally evaluated at the population level, although low-abundance guides still require attention to avoid underrepresentation and loss during amplification or selection.

In contrast, experiments involving quantitative comparisons across hundreds of candidate targets, or NGS capture workflows requiring consistent probe representation, may be more sensitive to abundance bias.

In these applications, differences in oligo abundance should be evaluated through NGS and, where appropriate, accounted for during data analysis rather than automatically treated as negligible variation.

Synbio Technologies offers optional NGS-based evaluation for chip-synthesized oligo pools, allowing customers to assess the actual abundance distribution of their libraries rather than relying solely on platform-level specifications.


2. Oligo Pool Quality Cannot Be Defined by a Single Error Rate

Sequence error rate is another commonly used metric when evaluating oligo pool quality. For example, chip-based synthesis may achieve error rates as low as 1 error per 2,000 nucleotides.

However, this number needs to be interpreted in the context of oligo length and downstream application. More importantly, the functional consequences depend on where an error occurs and what type of error is introduced.

Consider a 200-nt oligo synthesized at an error rate of 1 error per 2,000 nucleotides.

Assuming independent, uniformly distributed errors, the expected number of errors per molecule is approximately 0.1. This translates to roughly 9.5% of molecules carrying at least one error.

Not all errors have the same functional impact:

  • Single-nucleotide substitutions: A substitution within the seed region of a CRISPR sgRNA may alter target recognition and potentially affect off-target activity.

  • Hybridization-region mismatches: A substitution within the core hybridization region of an NGS capture probe may reduce binding efficiency and introduce target-dependent capture bias.

  • Insertions and deletions (indels): These can have more substantial consequences, particularly when they disrupt reading frames or critical sequence elements.

Unlike individually synthesized and purified oligos, chip-based oligo pools are generally not subjected to single-sequence purification. As a result, individual molecules carrying synthesis errors cannot simply be removed through conventional purification of each oligo.

This is an inherent characteristic of the chip-based synthesis approach, not necessarily an indication of poor manufacturing quality.

What matters is whether the supplier communicates these limitations transparently and provides appropriate quality assessment options to help customers understand the composition of their pools.

Ultimately, sequence fidelity should be evaluated alongside abundance uniformity, oligo length, and the requirements of the intended application.


3. Case Study: Why Experimental Planning Should Start Before Synthesis

A recent customer case highlighted another critical factor in oligo pool projects: experimental design.

The challenge was not synthesis throughput, but amplification specificity when multiple libraries were pooled together. After dozens of libraries were amplified simultaneously, nonspecific amplification became a major obstacle.

The issue was ultimately resolved by reorganizing the libraries into separate pools.

This case illustrates an important distinction: while chip-based synthesis provides the capacity to manufacture large-scale oligo libraries, successful project execution also depends on how those libraries are designed, organized, and handled before and after synthesis.

In this project, Synbio Technologies identified the potential amplification-specificity issue during the pre-sales consultation and recommended a split-pool strategy to improve downstream compatibility.

This approach reflects a broader consideration in high-throughput synthesis.

When a project involves hundreds of thousands or even millions of sequences, an early design decision can have a substantial impact on subsequent amplification, sequencing, and screening workflows. If a problem is identified only after synthesis, the time and cost associated with repeating the process can be considerable.

That is why pre-synthesis consultation, library partitioning, and pool optimization should be treated as integral parts of project planning—not simply as post-synthesis troubleshooting.


oligo pool


4. Beyond Specifications: Building a More Predictable Oligo Pool Workflow

For chip-based oligo pool synthesis, Synbio Technologies' Syno® platform provides the following core specifications:

- Synthesis throughput: Up to 1 million oligos per pool

- Oligo length: 20–300 nt

- Sequence error rate: Approximately 1:2,000–1:3,000 per nucleotide

 

These specifications establish the platform's manufacturing capabilities. However, two additional considerations are equally important when evaluating a supplier.

1. NGS-Based Quality Evaluation

2. Collaborative Project Planning

The goal is not simply to deliver a large number of oligos, but to provide a pool that is better aligned with its intended application.


Conclusion

Choosing a chip-based oligo synthesis provider should involve more than comparing throughput, oligo length, or nominal error rates.

Specifications determine whether a supplier can take on your project. Quality control and workflow planning determine how reliably that project can support your experiments.As oligo pool applications become increasingly complex, the focus should shift from how many sequences can be synthesized to how consistently and reliably those sequences can be used.

A high-throughput synthesis platform is the starting point. A well-characterized, application-ready oligo pool is the real objective.

  • Address:
    9 Deer Park Dr., Suite J-25
    Monmouth Junction, NJ 08852

This website stores cookies on your computer. These cookies are used to collect information about how you interact with our website and allow us to remember you.
To find out more about the cookies we use, see our Privacy Policy.

Accept